GPs face vacuum on CKD drug data
GPs are being forced to deal with spiralling workload on chronic kidney disease without the drug information they need to prescribe safely.
The information provided even on common medications is 'far too vague', the Drug and Therapeutics Bulletin has warned.
Dr Ike Iheanacho, editor of the DTB, said: 'There isn't a lot of information for a lot of the commonly used drugs or the information is very vague. It's potentially a very confusing area.'
The DTB said prescribing information in the summary of product characteristics was 'often unhelpful', and suggested ß-blockers and some analgesics and antidepressants were among drugs that might need adjusting by dosage in CKD
The report from the DTB came as a Pulse snap survey of GPs revealed as many as 43 per cent lacked confidence in treating the condition.
There was widespread anger over the introduction of the disease into the contract, with some 85 per cent believing it had not been well handled.
Dr Relton Cummings, chair of Newcastle LMC, said: 'I don't think anyone appreciated the amount of work involved or the time taken to explain to our more anxious patients that
although their creatinines haven't budged in years they now have "chronic kidney disease" that isn't going to get worse but now requires risk-
factor modification. It was
Dr John Cormack, a GP in South Woodham Ferrers, Essex, added: 'It was so badly handled that, in any other organisation, heads would roll.'